P285Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Autor:	Howard Rutman, R. De Caterina, H Lanz, E Braunwald, Michele Mercuri, Rose A. Hamershock, Sabina A. Murphy, Christian T. Ruff, Robert P. Giugliano, Elliot M Antman
Rok vydání:	2018
Předmět:	medicine.medical_specialty business.industry Warfarin Atrial fibrillation medicine.disease Outcome (game theory) chemistry.chemical_compound chemistry Edoxaban Internal medicine Cardiology Medicine In patient Cardiology and Cardiovascular Medicine business TIMI medicine.drug
Zdroj:	European Heart Journal. 39
ISSN:	1522-9645 0195-668X
DOI:	10.1093/eurheartj/ehy564.p285
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1c3f0db67ebd36e88fd05f142b2f89d0 https://doi.org/10.1093/eurheartj/ehy564.p285 Zobrazit plný text záznamu